Harald Kogler

Ingelheim Am Rhein, RP, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Novel cathepsin C inhibitor, BI 1291583, intended for treatment of bronchiectasis: Phase I characterization in healthy volunteers.

Novel cathepsin C inhibitor, BI 1291583, intended for treatment of bronchiectasis: Phase I characterization in healthy volunteers.

Journal: Clinical and translational science

Published: May 16, 2024

The preclinical and phase 1 development of the novel oral cathepsin C inhibitor BI 1291583.

The preclinical and phase 1 development of the novel oral cathepsin C inhibitor BI 1291583.

Journal: ERJ open research

Published: September 29, 2023

Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study.

Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study.

Journal: Respiratory research

Published: July 31, 2023

A Risk Prediction Model for Mortality Among Smokers in the COPDGene® Study.

A Risk Prediction Model for Mortality Among Smokers in the COPDGene® Study.

Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)

Published: September 03, 2020

COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.

COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.

Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)

Published: November 12, 2019

Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials.

Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials.

Journal: Respiratory research

Published: May 17, 2018

Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.

Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.

Journal: The Lancet. Respiratory medicine

Published: January 28, 2014

Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotropium in COPD trial.

Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotropium in COPD trial.

Journal: Chest

Published: November 29, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026